Current Phase 3 trials (expected to report results in 2027) are exploring doses ranging from 4mg to 12mg weekly, with some protocols testing up to 16mg
For any questions about your order, our research support team is available via email, phone, or text, seven days a week
Trulicity is also approved to lower the risk of major cardiovascular events such as heart attack or stroke in adults with type 2 diabetes and heart disease
Henry Meds patients experience similar outcomes when they adhere to treatment protocols and maintain follow-up consultations
If hunger remains the main barrier, GLP-1 for weight loss can quiet cravings and support consistency, often through Weight loss injections guided by a clinician
Oral versions of these medications are also in development